Literature DB >> 10713242

Wound healing after photorefractive keratectomy.

P Fagerholm1.   

Abstract

For more than 15 years, the excimer laser has been used as a surgical instrument on the cornea. Photorefractive keratectomy (PRK) followed radial keratotomy as researchers sought a more precise technique. In PRK, precision turned out to depend on surgical technique as well as the wound-healing process, with the 2 factors interdependent. The PRK technique has evolved toward a large diameter, flat ablation curvatures, and an even surface. The role of such factors as cytokines and interleukins has become more clear in the past 10 years. However, understanding the wound-healing process becomes more complicated with increasing know edge. Learning the contributing factors and performing trials with new drugs and antibodies to modulate wound healing have shown positive results on the experimental level. Patient selection based on the concentration of epidermal growth factor in tears may be another way to increase PRK s precision. The PRK technique has taught much about wound healing. For the technique to be competitive, increased precision, particularly in eyes with high myopia, is needed. Two other factors are imperative: controlling postoperative pain and decreasing visual rehabilitation time.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713242     DOI: 10.1016/s0886-3350(99)00436-8

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  9 in total

1.  Corneal wound healing after photorefractive keratectomy: a 3-year confocal microscopy study.

Authors:  Jay C Erie
Journal:  Trans Am Ophthalmol Soc       Date:  2003

2.  Combined phototherapeutic keratectomy and therapeutic contact lens for recurrent erosions in bullous keratopathy.

Authors:  P Y Lin; C C Wu; S M Lee
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

3.  The role of ultraviolet-B in corneal healing following excimer laser in situ keratomileusis.

Authors:  Zoltán Zsolt Nagy; Jeannette Tóth; Attila Nagymihály; Ildikó Süveges
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

4.  Comparison of bandage contact lens removal on the fourth versus seventh postoperative day after photorefractive keratectomy: A randomized clinical trial.

Authors:  Mehrdad Mohammadpour; Delaram Shakoor; Hassan Hashemi; Mohamad Aghaie Meybodi; Fateme Rajabi; Pegah Hosseini
Journal:  J Curr Ophthalmol       Date:  2016-09-23

5.  Post-photorefractive Keratectomy Pain and Corneal Sub-basal Nerve Density.

Authors:  Masoumeh Mohebbi; Amin Rafat-Nejad; Seyed-Farzad Mohammadi; Kosar Asna-Ashari; Maryam Kasiri; Saeed Heidari-Keshel; Farshad Askarizadeh
Journal:  J Ophthalmic Vis Res       Date:  2017 Apr-Jun

6.  Oral l-Cysteine Supplementation Enhances the Long Term-Effect of Topical Basic Fibroblast Growth Factor (bFGF) in Reducing the Corneal Haze after Photorefractive Keratectomy in Myopic Patients.

Authors:  Alessandro Meduri; Loredana Bergandi; Pietro Perroni; Francesca Silvagno; Pasquale Aragona
Journal:  Pharmaceuticals (Basel)       Date:  2020-04-15

7.  In vivo biocompatibility evaluation of in situ-forming polyethylene glycol-collagen hydrogels in corneal defects.

Authors:  Yoon Hong Chun; Sun-Kyoung Park; Eun Jeong Kim; Hyun Jong Lee; Hyewon Kim; Won-Gun Koh; Gabriella Fernandes Cunha; David Myung; Kyung-Sun Na
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.996

8.  Corneal Epithelial Removal with a Newly Designed Epithelial Brush.

Authors:  Ho Seok Chung; Seung Hwan Moon; Soon-Suk Kang; Minseop Kim; Hun Lee; Hungwon Tchah; Jae Yong Kim
Journal:  J Ophthalmol       Date:  2021-11-16       Impact factor: 1.909

9.  Effect of the combination of basic fibroblast growth factor and cysteine on corneal epithelial healing after photorefractive keratectomy in patients affected by myopia.

Authors:  Alessandro Meduri; Lucia Scorolli; Sergio Zaccaria Scalinci; Pier Luigi Grenga; Stefano Lupo; Miguel Rechichi; Enrico Meduri
Journal:  Indian J Ophthalmol       Date:  2014-04       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.